LifeStance Health Group, Inc. - 8-K Filing
LifeStance Health Group reports Q3 2026 revenue of $455.9 million and raises full-year 2026 guidance. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $LFST
Read the full article at SEC EDGAR
Part of the story Sinclair Inc. Raises Adjusted EBITDA Guidance Amid Strong Political Revenue Forecast (5 articles)